The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Cancer Policy

Heidi Overton selected as FDA commissioner; Jared Seehafer named inaugural Deputy Commissioner for Technology and AI

FDA authorizes second e-cigarette with age-gating features

Pentagon temporarily rescinds guidance on testosterone testing for U.S. military

Trump’s vaccine executive order draws criticism from medical community, may put cancer populations at risk

Senate passes stopgap bill that would ban OMB from finalizing rule that would politicize science

ACS CAN voter poll finds overwhelming support for affordable cancer care, high concern over tobacco usage

Clinical Roundup

ASTRO updates guideline on radiation therapy for pancreatic cancer

Alcohol-attributable cancer deaths in the U.S. doubled between 1990 and 2023, Sylvester-led study shows

Zipalertinib + chemo meets primary endpoint in phase III REZILIENT3 trial in first-line EGFR exon 20 insertion mutation NSCLC

Dietary supplement glutamine + standard therapy improved outcomes in advanced pancreatic cancer, Cedars-Sinai investigators find

Botensilimab + balstilimab showed no CRC recurrences in resectable colon cancer, phase II NEST trial shows

Blood cancer patients may have broader stem cell donor options than previously thought, ACCESS trial shows

In The Clinic
FreeGuest Editorial

Like it or not, AI psycho-oncology care is already happening. Urgently needed: An ethical framework
Developers and mental health providers must share the same goal: Safe, equitable, trustworthy, and patient-centered care

Guest Editorial
Trials & Tribulations
Trials & Tribulations
Trials & Tribulations

The Cancer Letter is an independent weekly news publication and the leading source for information on the issues that shape oncology.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account